$MREO Income Statement | Understand Stock

$MREO

$0.29 +$0.02 (6.07%) Close

Financial Statements

In millions of GBP; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cost of revenue
Research and development expenses
Administrative expenses
Operating loss
Net income recognized on acquisition of subsidiary
Finance income
Finance costs
Changes in the fair value of financial instruments
Gain/(loss) on disposal of intangible assets
Net foreign exchange gain/(loss)
Other income and expenses
(Loss)/profit before tax
Taxation
(Loss)/profit for the year, attributable to equity holders of the parent
Currency translation of foreign operations
Total comprehensive (loss)/income for the year, attributable to equity holders of the parent
Basic (loss)/profit per share for the year (in £)
Diluted loss per share for the year (in £)
Revenue
Operating expenses
Cost of Revenue
Research and development
General and administrative
Other income
Loss from operations
Other income/(expenses)
Interest income
Interest expense
Changes in the fair value of warrants
Foreign currency transaction (loss)/gain, net
Benefit from research and development tax credit
Net loss before income tax
Income tax benefit
Net loss
Loss per share - basic
Loss per share - diluted
Weighted average shares outstanding - basic
Weighted average shares outstanding - diluted
Other comprehensive income/(loss) - Foreign currency translation adjustments, net of tax
Total comprehensive loss

Comments